Lead the Central US Key Account Manager team in Hematology/Oncology rare disease specializing in identification and treatment of patients with idiopathic multicentric Castleman MMO disease (iMCD). Responsible for regional strategy, KOL development, KAM development and sales results.Skills:Team Leasership, Sales Strategy and implementation, cross functional team leadership, collaboration, KOL development,

Account readiness for launch of Lifileucel Cell Therapy in the Central United States. Development and implementation of strategy to ensure successful product launch in key accounts across the region. Close collaboration with cross functional teams to ensure account readiness. Building of a dynamic, high performance team across the Central US to bring this transformational therapy to patients.

Sirtex Medical -Dallas, TX July 2022-presentArea Oncology Manager-South Central USHighly Strategic and Clinical Sales Leadership position working with Regional Sales Managers in the South-Central US to educate and drive referrals for Y90 SIRT therapy (targeted radiation) for metastatic colorectal cancer. Target major cancer centers including Texas Oncology, UT Southwestern, MD Anderson, Baylor Sammons, UT Houston, The Methodist Hospital-HoustonAchievements:Developed and implemented high impact Oncology Strategies for the South Central TeamCoached team to drive referrals for y90 from oncologists to Interventional RadiologistsSales increased by 44% from first half to second half of 2022 due to new referrals Propelled South Central Region to #1 from #5 of 9 regions to goal in 2022Area of the Year sales award due to quick impact on oncology referrals.

Built and led an exceptional sales and cross funtional team in targeted gene therapy, Zolgensma, in Spinal Muscular Atrophy, an ultra rare neuromuscular condition in infants. Responsible for all sales and marketing to pediatric neuromuscular physicians and other associated health care professionals in the Southern US.The South Team has been an integral part of the most successful launch of of an ultra orphan therapy in biopharmaceutical history• Most successful ultra-orphan drug launch in history-established Zolgensma as the standard of care in the treatment of SMA in patients under 2 years of age• South Team performance consistently excellent since launch in May 2019• Rated “Exceptional Performance for RBD role in 2019• South Team has been extraordinarily successful in launch Zolgensma in 36 major Children’s Hospitals across the Southern US including Texas Children’s Hospital, Dallas Children’s, Nemours Orlando, Shands Children’s, Children’s of Atlanta. Duke Children’s etc.

Regional Sales Director-South Central USBuilt and led a high energy, highly talented technical sales team in Texas and Oklahoma launching and marketing eculizimab (Soliris) for two ultra-orphan blood disorders to Hematologists and Oncologists-PNH and Atypical Hemolytic Uremic Syndrome. Consistently ranked amongst very top Regional Sales Managers in all aspects-Sales, Leadership, Business Acumen, Motivational Skills, and Analytical Skills. • Consistently amongst top performers at Alexion in both Sales and Sales Leadership roles. #2 of 12 Regional Sales Managers in 2014 and 2015 and 2017 Net 100+ new patients over last 3 years at Alexion #1 in the company. Built region from ground up to over $ 100 million annual revenue-over $600 million revenue total.• Recruited, inspired, trained, developed, and mentored all 7 new regional sales reps and educate region members on clinical data. Built reputation as a leader in strategic selling and marketing as well as clinical expertise at Alexion • Developed key customer relationships and landed over 75 key accounts including Texas Oncology, MD Anderson Cancer Center, UTSW/Parkland, Baylor Medical Center, The Methodist Hospital, Baylor College of Medicine and many more.• Seen a leader amongst other RSD’s in developing effective strategies to help make their teams be more successful including Mid-Atlantic, Southwest, West, South, Southeast and Midwest Regions • Partnered with Marketing at Alexion to develop effective marketing strategies for both PNH and aHUS. Instrumental in developing marketing strategy and tactics surrounding thrombosis risk as the central theme in driving conversion identified patients to be treated across the US. • Rated “Exceeds Expectations” in sales performance as RSD in 2015-“Highly Successful” 2016, “Exceeds Expectations” in sales 2017.

Regional Account Manager (July 2008 – May 2013)Launched Soliris (eculizumab) across the North Texas region to Hematology, Oncology, Nephrology, and other categories for two ultra-rare blood disorders, PNH and aHUS. Increased disease awareness by educating thought leaders, internal stakeholders, and key healthcare professionals.Grew from 0 patients on therapy to 50+ patients on chronic treatment in <5 years to increase annual revenue by $25 million and reach #1 in sales performance at Alexion, 2012Achieved “Exceeds Expectations” in sales, 2011, 2012Earned recognition as a leader for clinical selling expertise and professional business acumen influence across the sales and marketing teamsWinner of Founders Club. #1 in Sales Performance in 2012

Regional Business Director (Central Region) Built and led an exceptional sales team of 15 to launch and develop a new, innovative treatment for two ultra orphan diseases in pediatric endocrine space. Held full strategic planning, budgeting, and sales incentive responsibilities. Challenged with driving sales, penetrating new markets, and positioning the company for long-term growth and expansion. Awarded Circle of Excellence & Regional Business Director of the Year in 2006 & 2007•Recruited, trained, developed, mentored, and led all sales personnel. Created high-impact, high-yield sales training programs that accelerated field immersion and drove immediate & long-term growth. Built a highly successfully sales team from scratch that accounted for 50% of all company sales.

Recruited to market and sell cutting-edge pharmaceuticals to interventional and clinical cardiologists at major medical centers in the Dallas/Ft. Worth areas. Promoted rapidly through a series of increasingly responsible leadership positions and successfully led the Midwest & Southwest Regions while currently directing the National Clinical Specialists which targeted top 100 accounts throughout the United States. Given full responsibility for all strategic planning and incentive/compensation plans. Had 14 direct reports.Won Two Millennium Cup and Regional Manager of the Year AwardsLed regions to achieve #1 total sales and sales growth in the United States. in 2003 & 2005.• Trained, developed & mentored new and existing sales reps in the Dallas/Ft. Worth territories. Personally ranked #1 in the region and #9 & #7 nationally (out of 100) in 1999 & 2000 respectively.• Successfully led both regions from underperforming to exceptionally high performance within 12 months. Led Clinical Specialists to drive sales in the top 100 accounts throughout the country.• Successfully managed, motivated, and led a highly-specialized group of sales reps & account managers to grow the cardiovascular business amidst intense market pressure.